Clinical Trials Directory

Trials / Unknown

UnknownNCT01487226

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

A Phase II Trial of Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in FIGO Stage IA2-IIA Cervical Cancer

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
69 (estimated)
Sponsor
Korean Gynecologic Oncology Group · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Purpose Primary endpoint * To evaluate the 3-year disease free survival Second endpoints * To evaluate the 3-year \& 5-year overall survival To analyze the toxicity and the quality of life

Conditions

Interventions

TypeNameDescription
DRUGpaclitaxelPaclitaxel 175 mg/m2 over 3 hr Repeat every 3 weeks \* 6 cycles
DRUGCisplatin 50mg/m2Cisplatin 50mg/m2 Repeat every 3 weeks \* 6 cycles

Timeline

Start date
2008-01-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2011-12-07
Last updated
2011-12-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01487226. Inclusion in this directory is not an endorsement.